• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异环磷酰胺所致严重肾功能不全时的浓缩功能

Concentrating capacity in ifosfamide-induced severe renal dysfunction.

作者信息

Rossi R, Gödde A, Kleinebrand A, Rath B, Jürgens H

机构信息

University Children's Hospital, Münster, Germany.

出版信息

Ren Fail. 1995 Sep;17(5):551-7. doi: 10.3109/08860229509037619.

DOI:10.3109/08860229509037619
PMID:8570867
Abstract

BACKGROUND

Diabetes insipidus renalis has only occasionally been reported in ifosfamide-induced renal Fanconi's syndrome, but in two studies on subclinical renal impairment, low morning urine osmolarity was found in high frequencies. This study was performed to assess the frequency of defective concentrating capacity in patients with ifosfamide-induced renal Fanconi's syndrome or severe impairment of proximal tubular function.

PATIENTS AND METHODS

Seven patients with overt Fanconi's syndrome and 5 with a generalized but subclinical tubulopathy were examined. Beside proximal tubular solute reabsorption and estimation of glomerular filtration rate, urinary osmolarity was measured after overnight fast and DDAVP (1-D-amino-8-D-arginine vasopressin) testing.

RESULTS

Five out of 7 patients with overt Fanconi's syndrome, but no patient with only subclinical tubular damage, had decreased osmolarities by at least one test. Increased sodium excretion was additionally found in 4 of these patients.

CONCLUSION

Impaired renal concentrating capacity is a rare event in ifosfamide-induced renal dysfunction and confined to patients with overt Fanconi's syndrome. These patients should, however, undergo evaluation of concentrating capacity and renal sodium handling as decreased concentrating capacity and increased sodium excretion would render a patient at risk for dehydration episodes.

摘要

背景

肾性尿崩症仅偶尔在异环磷酰胺诱导的肾性范科尼综合征中被报道,但在两项关于亚临床肾功能损害的研究中,发现晨尿渗透压降低的频率较高。本研究旨在评估异环磷酰胺诱导的肾性范科尼综合征或近端肾小管功能严重损害患者中浓缩功能缺陷的频率。

患者与方法

对7例显性范科尼综合征患者和5例广泛性但亚临床肾小管病患者进行了检查。除了近端肾小管溶质重吸收和肾小球滤过率评估外,还在过夜禁食和去氨加压素(1-D-氨基-8-D-精氨酸加压素)试验后测量了尿渗透压。

结果

7例显性范科尼综合征患者中有5例至少一项试验显示渗透压降低,但仅亚临床肾小管损伤的患者中无此情况。这些患者中有4例还发现钠排泄增加。

结论

在异环磷酰胺诱导的肾功能障碍中,肾浓缩功能受损是罕见事件,且仅限于显性范科尼综合征患者。然而,这些患者应进行浓缩功能和肾钠处理评估,因为浓缩功能降低和钠排泄增加会使患者有发生脱水发作的风险。

相似文献

1
Concentrating capacity in ifosfamide-induced severe renal dysfunction.异环磷酰胺所致严重肾功能不全时的浓缩功能
Ren Fail. 1995 Sep;17(5):551-7. doi: 10.3109/08860229509037619.
2
Fanconi's syndrome and nephrogenic diabetes insipidus in an adult treated with ifosfamide.成年患者接受异环磷酰胺治疗后出现范可尼综合征和肾性尿崩症。
Pharmacotherapy. 2012 Jan;32(1):e12-6. doi: 10.1002/PHAR.1013.
3
Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients.异环磷酰胺所致肾毒性的发展:75例患者的前瞻性随访
Med Pediatr Oncol. 1999 Mar;32(3):177-82. doi: 10.1002/(sici)1096-911x(199903)32:3<177::aid-mpo3>3.0.co;2-h.
4
Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients.单侧肾切除和顺铂作为异环磷酰胺诱导肾毒性的危险因素:120例患者的分析
J Clin Oncol. 1994 Jan;12(1):159-65. doi: 10.1200/JCO.1994.12.1.159.
5
Fanconi's syndrome due to ifosfamide.异环磷酰胺所致范科尼综合征
Bone Marrow Transplant. 1993 Jan;11(1):71-3.
6
Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.异环磷酰胺诱发的肾性范科尼综合征的肾小管功能及组织学表现——两例报告
Eur J Pediatr. 1992 May;151(5):384-7. doi: 10.1007/BF02113264.
7
Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum.异环磷酰胺诱导的亚临床肾毒性及其被顺铂增强的作用。
Med Pediatr Oncol. 1994;22(1):27-32. doi: 10.1002/mpo.2950220106.
8
[Ifosfamide-induced nephrotoxicity].异环磷酰胺诱导的肾毒性
Monatsschr Kinderheilkd. 1993 Jul;141(7):594-601.
9
Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis.通过尿蛋白分析评估异环磷酰胺/顺铂诱导的肾毒性。
Pediatr Nephrol. 1994 Apr;8(2):151-6. doi: 10.1007/BF00865464.
10
Ifosfamide, Fanconi's syndrome, and rickets.
J Clin Oncol. 1991 Aug;9(8):1495-9. doi: 10.1200/JCO.1991.9.8.1495.

引用本文的文献

1
Ifosfamide-induced nephrogenic diabetes insipidus and Fanconi syndrome in a patient with femur osteosarcoma.一名股骨骨肉瘤患者出现异环磷酰胺诱导的肾性尿崩症和范科尼综合征。
Caspian J Intern Med. 2024 Sep 7;15(4):743-747. doi: 10.22088/cjim.15.4.743. eCollection 2024 Fall.
2
Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin.异环磷酰胺诱导的肾性尿崩症对超生理剂量静脉注射去氨加压素有效。
Clin Nephrol Case Stud. 2021 Jul 1;9:87-92. doi: 10.5414/CNCS110589. eCollection 2021.
3
Drug-induced acute kidney injury in children.
儿童药物性急性肾损伤
Br J Clin Pharmacol. 2015 Oct;80(4):901-9. doi: 10.1111/bcp.12554. Epub 2015 Jun 1.
4
Endocrine sequelae of cancer and cancer treatments.癌症及癌症治疗的内分泌后遗症。
J Cancer Surviv. 2007 Dec;1(4):261-74. doi: 10.1007/s11764-007-0038-6. Epub 2007 Nov 20.
5
Osteomalacia as a late metabolic complication of Ifosfamide chemotherapy in young adults: illustrative cases and review of the literature.骨软化症作为异环磷酰胺化疗在年轻成年人中的晚期代谢并发症:病例说明及文献综述
Sarcoma. 2007;2007:91586. doi: 10.1155/2007/91586.